- Order Reprints
- Print Article
CVS Health beat analysts’ first-quarter earnings and revenue estimates but lowered guidance for the full year. The stock was falling in premarket trading Wednesday.
Summary
Summary
U.S
Europe
Asia
FX
Rates
Futures
ETFs
Crypto
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
https://www.barrons.com/articles/cvs-stock-earnings-d710e318
Related posts:
Good News for Seniors: RMD Formula Changing for First Time in Decades
Warren Buffett's Berkshire Confirms Apple Sale, Dumps This PC Maker, Finally Reveals Mystery Stock: ...
Barron’s Pick: This Industrial Stock Could Soar 40%
Gen Z should never work from home if they want success—or love, NYU professor says
Rising interest rates may be a good thing for home prices